References
- Dhaded S M, Kumar P, Narang A. Safe bilirubin level for term babies with non-hemolytic jaundice. Indian Pediatr. 1996;33:1059–60.
- Slusher T M, Zipursky A, Bhutani V K. A global need for affordable neonatal jaundice technologies. Semin Perinatol. 2011;35:185–91.
- American Academy of Pediatrics, Subcommittee on Hyperbilirubinaemia. Management of hyperbilirubinaemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
- Suresh K. Integrated diseases surveillance project (IDSP) through a consultant's lens. Indian J Public Health. 2008;52:136–43.
- Hartshorn D, Buckmaster A. ‘Halving the heel pricks’: evaluation of a neonatal jaundice protocol incorporating the use of a transcutaneous bilirubinometer. J Paediatr Child Health. 2010;46:595–9.
- Lease M, Whalen B. Assessing jaundice in infants of 35-week gestation and greater. Curr Opin Pediatr. 2010;22:352–65.
- Bhat Y, Rao A. Transcutaneous bilirubin in predicting hyperbilirubinaemia in term neonates. Indian J Pediatr. 2008;75:119–23.
- Bhutani V K, Gourley G R, Adler S, Kreamer B, Dalin C, Johnson L H. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinaemia. Pediatrics. 2000;106:E17.
- Bhutani V K, Johnson L, Sivieri E M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinaemia in healthy term and near-term newborns. Pediatrics. 1999;103:6–14.
- Mishra S, Chawla D, Agarwal R, Deorari A K, Paul V K, Bhutani V K. Transcutaneous bilirubinometry reduces the need for blood sampling in neonates with visible jaundice. Acta Paediatr. 2009;98:1916–19.
- Bhat Y R, Kumar C G. Morbidity of ABO haemolytic disease in the newborn. Paediatr Int Child Health. 2012;32:93–6.
- Sarici S U, Yurdakok M, Serdar M A, Oran O, Erdem G, Tekinalp G, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinaemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics. 2002;109:e53.
- Quinn M W, Weindling A M, Davidson D C. Does ABO incompatibility matter?Arch Dis Child. 1988;63:1258–60.
- Indian Foundation for Premature Birth. Delivered Too Soon: Action Report on Preterm Birth in India. Bangalore: Indian Foundation for Premature Birth, 2013.
- Lavanya K R, Jaiswal A, Reddy P, Murki S. Predictors of significant jaundice in late preterm infants. Indian Pediatr. 2012;49:717–20.
- Bhutani V K. Late preterm births – major cause of prematurity and adverse outcomes of neonatal hyperbilirubinaemia. Indian Pediatr. 2012;49:704–5.
- Rylance S, Yan J, Molyneux E. Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi?Paediatr Int Child Health. 2014;34:101–7.